Microsoft has released ASP.NET Core in .NET 11 Preview 1, introducing new Blazor components like EnvironmentBoundary, Label, and DisplayName, along with relative URI navigation, QuickGrid row click ...

Ready to build secure, cloud-native solutions in a collaborative digital team where your ideas truly matter? Our cient is looking for someone for a 10 week project working remotely from SA and working ...

IT company with over 17 years of experience specializing in custom software development, mobile app creation, and web development, is seeking a high-caliber Senior C# Developer to join their dynamic ...

The blog recommended that users learn to train their own AI models by downloading the Harry Potter dataset and then uploading text files to Azure Blob Storage. It included example models based on a ...

AI coding assistants and agentic workflows represent the future of software development and will continue to evolve at a rapid pace. But while LLMs have become adept at generating functionally correct ...

Mr. Shirky, a vice provost at New York University, has been helping faculty members and students adapt to digital tools since 2015. Back in 2023, when ChatGPT was still new, a professor friend had a ...

.NET began as a Windows-focused framework before being completely reworked into a modern, cross-platform ecosystem. Today, it powers web apps, mobile apps, games, enterprise systems, and more. Its ...

Self-driving trucks company Kodiak AI announced on Monday it is working with global automotive supplier Bosch to develop a system of hardware and software that can give standard big rigs autonomous ...

Palantir Technologies Inc. (NASDAQ:PLTR) is one of the most profitable tech stocks to buy. On December 4, Palantir Technologies, Nvidia (NASDAQ:NVDA), and US utility CenterPoint Energy (NYSE:CNP) ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

WALTHAM, Mass. & MONTREAL--(BUSINESS WIRE)--Ventus Therapeutics, a clinical-stage biopharmaceutical company advancing two Phase 2 small-molecule programs for immunological, inflammatory, and ...